First human trial of potential coronavirus antibody treatment begins: Top updates on Covid-19 vaccine
By hindustantimes.com | Edited by Sparshita Saxena | Hindustan Times, New Delhi
UPDATED ON JUN 03, 2020 03:57 PM IST
India has approved Gilead Sciences Inc’s antiviral drug remdesivir for emergency use for five doses in treating Covid-19 patients.
By Aurangzeb Naqshbandi | Hindustan Times, New Delhi
UPDATED ON MAY 27, 2020 01:55 PM IST
Ashish Jha is a professor of Global Health at TH Chan School of Public Health and director, Harvard Global Health Institute.
By hindustantime.com | Edited by Sparshita Saxena | Hindustan Times, New Delhi
UPDATED ON MAY 18, 2020 07:34 PM IST
According to the World Health Organization, 8 candidate vaccines for Covid-19 are currently in the clinical evaluation phase.
By Press Trust of India | New Delhi
PUBLISHED ON MAY 09, 2020 08:51 PM IST
The vaccine will be developed using the virus strain isolated at the ICMR’s National Institute of Virology (NIV), Pune, a statement said.